NO20073980L - Nye farmasoytiske blandinger - Google Patents

Nye farmasoytiske blandinger

Info

Publication number
NO20073980L
NO20073980L NO20073980A NO20073980A NO20073980L NO 20073980 L NO20073980 L NO 20073980L NO 20073980 A NO20073980 A NO 20073980A NO 20073980 A NO20073980 A NO 20073980A NO 20073980 L NO20073980 L NO 20073980L
Authority
NO
Norway
Prior art keywords
pharmaceutical compositions
new pharmaceutical
size
promoting
particles
Prior art date
Application number
NO20073980A
Other languages
English (en)
Inventor
Christer Nystrom
Nelly Fransen
Erik Bjork
Original Assignee
Orexo Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orexo Ab filed Critical Orexo Ab
Publication of NO20073980L publication Critical patent/NO20073980L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

Farmasøytisk blanding i form av homogene interaktive blandinger omfatter en farmakologisk effektiv mengde av en aktiv bestanddel i form av mikropartikler med størrelse i området fra 0,5 Tm til 10 Tm. Partiklene er festet til overflatene av større bærerpartikler med en størrelse i området fra 10 til 100 Tm. Bærerpartikkelmaterialet er fortrinnsvis bioadhesjons-fremmende og/eller mukosadhesjonsfremmende av natur.
NO20073980A 2005-02-10 2007-07-31 Nye farmasoytiske blandinger NO20073980L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65121005P 2005-02-10 2005-02-10
PCT/GB2006/000481 WO2006085101A2 (en) 2005-02-10 2006-02-10 Pharmaceutical compositions useful in the transmucosal administration of drugs

Publications (1)

Publication Number Publication Date
NO20073980L true NO20073980L (no) 2007-11-05

Family

ID=34956592

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20073980A NO20073980L (no) 2005-02-10 2007-07-31 Nye farmasoytiske blandinger

Country Status (13)

Country Link
US (1) US20080317863A1 (no)
EP (1) EP1845946A2 (no)
JP (1) JP2008530070A (no)
KR (1) KR20070111497A (no)
CN (1) CN101132769A (no)
AU (1) AU2006212021B2 (no)
CA (1) CA2601969A1 (no)
IL (1) IL184758A0 (no)
MX (1) MX2007009635A (no)
NO (1) NO20073980L (no)
NZ (1) NZ556717A (no)
RU (1) RU2007133503A (no)
WO (1) WO2006085101A2 (no)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
WO2004056363A2 (en) 2002-12-20 2004-07-08 Niconovum Ab A physically and chemically stable nicotine-containing particulate material
US10172810B2 (en) * 2003-02-24 2019-01-08 Pharmaceutical Productions, Inc. Transmucosal ketamine delivery composition
GB0327723D0 (en) 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8679545B2 (en) 2005-11-12 2014-03-25 The Regents Of The University Of California Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
US8324192B2 (en) 2005-11-12 2012-12-04 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
CA2646942C (en) 2006-03-16 2014-07-29 Niconovum Ab Improved snuff composition
WO2008067573A2 (en) * 2006-12-01 2008-06-05 Tshwane University Of Technology Drug delivery system
RU2472539C2 (ru) 2007-08-06 2013-01-20 Аллерган, Инк. Способы и устройства для доставки препарата десмопрессина
EP2197430A2 (en) * 2007-09-18 2010-06-23 NicoNovum AB Stable chewing gum compositions comprising maltitol and providing rapid release of nicotine
WO2009064458A2 (en) * 2007-11-13 2009-05-22 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
US20090131386A1 (en) 2007-11-13 2009-05-21 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
CA2736531C (en) * 2008-09-17 2016-10-25 Niconovum Ab Process for preparing snuff composition
JP5472756B2 (ja) 2008-10-02 2014-04-16 マイラン・インク 多層接着ラミネートの作製方法
TR201902233T4 (tr) 2009-10-30 2019-03-21 Ix Biopharma Ltd Hızlı çözünen katı dozaj formu.
WO2011080502A2 (en) 2009-12-29 2011-07-07 Orexo Ab New pharmaceutical dosage form for the treatment of gastric acid-related disorders
WO2011150320A2 (en) * 2010-05-27 2011-12-01 University Of Georgia Research Foundation, Inc. Activators of innate immunity
CN102309456B (zh) * 2010-07-02 2013-05-01 北京化工大学 一种厄贝沙坦纳微复合粉体与片剂及其制备方法
US9532977B2 (en) 2010-12-16 2017-01-03 Celgene Corporation Controlled release oral dosage forms of poorly soluble drugs and uses thereof
WO2012083017A2 (en) * 2010-12-16 2012-06-21 Celgene Corporation Controlled release oral dosage forms of poorly soluble drugs and uses thereof
BR112013020237A2 (pt) 2011-02-11 2021-03-16 Ctc Bio, Inc. Processo para preparar um filme contendo base livre de sildenafila e filme contendo base livre de sildenafila
CN102210646B (zh) * 2011-06-07 2013-07-31 辽宁成大生物股份有限公司 一种人用狂犬病疫苗凝胶剂及其制备方法
JP2015526481A (ja) * 2012-08-24 2015-09-10 ブイアール１ インコーポレイテッド 片頭痛の治療用組成物
US10792326B2 (en) * 2013-06-28 2020-10-06 Wellesley Pharmaceuticals, Llc Pharmaceutical formulation for bedwetting and method of use thereof
WO2015023675A2 (en) 2013-08-12 2015-02-19 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
EP3068396B1 (en) * 2013-11-11 2019-05-08 Impax Laboratories, Inc. Rapidly disintegrating formulations and methods of use
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
WO2015095391A1 (en) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
WO2016010771A1 (en) 2014-07-17 2016-01-21 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
CN106794155B (zh) * 2014-10-14 2020-10-30 久光制药株式会社 贴附剂
JP2017531026A (ja) 2014-10-20 2017-10-19 ファーマシューティカル マニュファクチュアリング リサーチ サービシズ，インコーポレーテッド 徐放性乱用抑止性液体充填剤形
WO2016161537A1 (en) * 2015-04-08 2016-10-13 Maxinase Life Sciences Limited Bioadhesive compositions for intranasal administration of granistron
EP3316865A4 (en) 2015-07-02 2019-01-23 Civitas Therapeutics, Inc. POWDERS CONTAINING TRIPTAN, FOR PULMONARY DELIVERY
SG11201805810PA (en) * 2015-09-01 2018-08-30 Wellesley Pharmaceuticals Llc Extended, delayed and immediate release formulation method of manufacturing and use thereof
EP4091601A1 (en) * 2016-01-07 2022-11-23 Viramal Limited Gel compositions for transdermal delivery to maximize drug concentrations in the stratum corneum and serum and methods of use thereof
CA3048360C (en) * 2016-12-26 2021-06-29 Shionogi & Co., Ltd. Production method for formulation having improved content uniformity
CN107233359A (zh) * 2017-06-08 2017-10-10 黄成林 一种治疗痔疮的药物组合物、制剂及其制备方法
WO2018236678A1 (en) 2017-06-20 2018-12-27 Physician's Seal, LLC ORAL DISSOLUTION MELATONIN FORMULATION WITH ACIDIFYING AGENT THAT MAKES MELATONIN SOLUBLE IN SALIVA
US10653690B1 (en) 2019-07-09 2020-05-19 Orexo Ab Pharmaceutical composition for nasal delivery
US10729687B1 (en) 2019-07-09 2020-08-04 Orexo Ab Pharmaceutical composition for nasal delivery
CA3178769A1 (en) 2020-05-18 2021-11-25 Jonas Savmarker New pharmaceutical composition for drug delivery
AR127780A1 (es) 2021-11-25 2024-02-28 Orexo Ab Nueva composición farmacéutica que comprende adrenalina

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4721709A (en) * 1984-07-26 1988-01-26 Pyare Seth Novel pharmaceutical compositions containing hydrophobic practically water-insoluble drugs adsorbed on pharmaceutical excipients as carrier; process for their preparation and the use of said compositions
US4712709A (en) * 1986-04-28 1987-12-15 Horvath Ronald F Fuel-intake device for vehicle tank
SE8800080L (sv) * 1988-01-13 1989-07-14 Kabivitrum Ab Laekemedelskomposition
SE8803935L (sv) * 1988-10-31 1990-05-01 Kabivitrum Ab Laekemedelskomposition
EP0588255A1 (en) * 1992-09-12 1994-03-23 Dott Limited Company Physiologically active peptide compositions
SE9803240D0 (sv) * 1998-09-24 1998-09-24 Diabact Ab A pharmaceutical composition having a rapid action
US6197328B1 (en) * 1999-08-20 2001-03-06 Dott Research Laboratory Nasally administrable compositions
RU2345791C2 (ru) * 2003-01-31 2009-02-10 Орексо Аб Быстродействующая фармацевтическая композиция

Also Published As

Publication number Publication date
MX2007009635A (es) 2007-09-25
RU2007133503A (ru) 2009-03-20
WO2006085101A2 (en) 2006-08-17
NZ556717A (en) 2010-09-30
US20080317863A1 (en) 2008-12-25
JP2008530070A (ja) 2008-08-07
WO2006085101A3 (en) 2006-11-23
KR20070111497A (ko) 2007-11-21
CN101132769A (zh) 2008-02-27
AU2006212021A1 (en) 2006-08-17
AU2006212021B2 (en) 2010-09-30
EP1845946A2 (en) 2007-10-24
CA2601969A1 (en) 2006-08-17
IL184758A0 (en) 2007-12-03

Similar Documents

Publication Publication Date Title
NO20073980L (no) Nye farmasoytiske blandinger
DE602006011288D1 (de) Mentholhaltige feststoffzusammensetzung
WO2007053197A3 (en) Nanoparticulate acetaminophen formulations
SG170047A1 (en) Nanoparticulate posaconazole formulations
SG170087A1 (en) Pharmaceutical compositions
ES2572157T3 (es) Composiciones en forma de partículas para la administración de fármacos poco solubles
ATE419835T1 (de) Nystatin-nanopartikelzusammensetzungen
WO2007086914A3 (en) Nanoparticulate clopidogrel formulations
NZ710384A (en) A novel formulation of indomethacin
MX2007012802A (es) Composicion farmaceutica en aerosol.
ITMI20051999A1 (it) Formulazioni inalatorie di farmaci in fora di polvere secca per somministrazione come tale o con nebulizzatore e dotate di elevata erogabilita' respirabilita' e stabilita'
RU2006142322A (ru) Фармацевтические композиции
MX2009010989A (es) Composiciones farmaceuticas liofilizadas y metodos de obtener y usar las mismas.
WO2006103407A3 (en) New pharmaceutical compositions useful in the treatment of migraine
TW200640459A (en) Particulate-stabilized injectable pharmaceutical compositions of posaconazole
MX2008001645A (es) Composiciones de fexofendina en suspension farmaceutica oral.
WO2009050726A3 (en) Compositions and methods for improved delivery of bupropion
MX2009000849A (es) Formas de dosificacion liofilizadasdisolvibles oralmente/desintegrables que contienen particulas protegidas.
WO2006034397A3 (en) Coating composition
WO2006041843A3 (en) Pharmaceutical dosage form comprising meloxicam
WO2006138421A3 (en) Nanoparticulate azelnidipine formulations
AR073573A1 (es) Metodos para utilizar composiciones de aminopiridina de liberacion sostenida
WO2008062475A3 (en) Pharmaceutical compositions of ursodiol
WO2012154805A3 (en) Sprayable compositions for reducing particulates in the air
TR200504890T1 (tr) Benipidin hidroklorür içeren farmasötik bileşim

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application